Therapeutic Group: Oncology Presentation Lapacent 250: Each tablet contains Lapatinib ditosylate monohydrate INN equivalent to Lapatinib 250 mg Description Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both Epidermal Growth Factor Receptor (EGFR [ErbB1]) and of Human Epidermal Receptor Type 2 (HER2 [ErbB2]) receptors (estimated Kiapp values of 3nM and […]